Taking the differential expression between tumor and adjacent normal samples into consideration, it can be observed that the lipid-metabolism related genes, such as MMP1, HMGCS2 and AKR1C3, may not only be diagnosis markers for tumors but also may act as prognosis biomarkers in different tumor samples. This evidence concerns the gene MMP1 and neoplasm.